For the reliable and safe production and delivery of high-quality radiopharmaceutical products our production sites maintain production environments in conformity with the latest Good Manufacturing Practice (GMP).In addition to production sites in Chiba (Sodegaura) and Hyogo (Sanda) for SPECT products we established PET laboratories across the country for our entry into the PET business.All of our employees demonstrate professionalism and are devoted day and night to ensuring excellent quality keeping in mind the maintenance and enhancement of a clean environment for pharmaceutical production as well as strict environmental and safety controls adequate for RI-handling facilities.
Chiba Facility
Hyogo Facility
PET Laboratory
Quality Assurance and Safety Control
Guided by our principle of "providing the highest quality," we maintain high ethical standards and comply with prevalent pharmaceutical laws and regulations to ensure a stable supply of high-quality, safe products and services that contribute to people’s health and well-being. To establish a legal compliance system, we will clarify the matters requiring compliance as a licensed business operator, the organizational structure, responsibilities, authority, and interrelationships, thereby promoting appropriate and smooth implementation of business operations. Additionally, to ensure the quality and stable supply of the pharmaceuticals and medical devices we provide, we will establish a quality-assurance system encompassing the entire product lifecycle, strengthen the coordination of activities from product development to delivery to customers, and promote continuous improvement.
Domestic Production Sites and Products for Delivery
SPECT diagnostics are shipped from two manufacturing facilities in Chiba and Hyogo Prefectures and PET diagnostics having a shorter half-life of two hours are shipped from ten PET laboratories across the country.
Providing safety and stable operation day and night these production sites have established a mutual backup system to avoid negative effects on both medical institutions and patients even if troubles occur with the production sites or transportation networks caused by disaster or bad weather.
Since the supply areas for PET diagnostics produced in the PET laboratories are limited we are reinforcing our 11 PET laboratories across the country to ensure stable supply.
